1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Acer Therapeutics Inc (ACER)
  7. Quote


Acer Therapeutics Stock Price

-0.14 (-7.04%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 45,350
Bid Price 1.80
Ask Price 2.10
News (1)
Day High 2.00


52 Week Range


Day Low 1.86
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acer Therapeutics Inc ACER NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.14 -7.04% 1.85 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.00 1.86 2.00 1.88 1.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
397 45,350 $ 1.90 $ 86,248 - 1.86 - 5.39
Last Trade Time Type Quantity Stock Price Currency
18:53:41 1 $ 1.85 USD


Draw Mode:

Acer Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 26.47M 14.31M 9.44M $ - $ - -2.06 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 223.57k -

more financials information »

Acer Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACER Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.202.251.862.0662,951-0.35-15.91%
1 Month2.462.661.862.3172,620-0.61-24.8%
3 Months2.693.041.862.77314,547-0.84-31.23%
6 Months2.883.141.862.74264,204-1.03-35.76%
1 Year2.695.391.863.46522,568-0.84-31.23%
3 Years23.4028.24751.084.06280,673-21.55-92.09%
5 Years8.5534.101.084.77209,453-6.70-78.36%

Acer Therapeutics Description

Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.

Your Recent History
Acer Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.